82 related articles for article (PubMed ID: 2208168)
1. Phenobarbital enhances the formation of reactive oxygen in neoplastic rat liver nodules.
Scholz W; Schütze K; Kunz W; Schwarz M
Cancer Res; 1990 Nov; 50(21):7015-22. PubMed ID: 2208168
[TBL] [Abstract][Full Text] [Related]
2. Influence of dietary thiamin on phenobarbital induction of rat hepatic enzymes responsible for metabolizing drugs and carcinogens.
Wade AE; Evans JS; Holmes D; Baker MT
Drug Nutr Interact; 1983; 2(2):117-30. PubMed ID: 6432511
[TBL] [Abstract][Full Text] [Related]
3. Development of cytochrome P-450-altered preneoplastic and neoplastic lesions during nitrosamine-induced hepatocarcinogenesis in the rat.
Buchmann A; Schwarz M; Schmitt R; Wolf CR; Oesch F; Kunz W
Cancer Res; 1987 Jun; 47(11):2911-8. PubMed ID: 3567909
[TBL] [Abstract][Full Text] [Related]
4. Reducing equivalents for mixed function oxidation in periportal and pericentral regions of the liver lobule in perfused livers from normal and phenobarbital-treated rats.
Belinsky SA; Kauffman FC; Thurman RG
Mol Pharmacol; 1984 Nov; 26(3):574-81. PubMed ID: 6333582
[TBL] [Abstract][Full Text] [Related]
5. Lucigenin as a substrate of microsomal NAD(P)H-oxidoreductases.
Schepetkin IA
Biochemistry (Mosc); 1999 Jan; 64(1):25-32. PubMed ID: 9986909
[TBL] [Abstract][Full Text] [Related]
6. Effect of treatment with phenobarbital and stiripentol on carbamazepine-induced teratogenicity and reactive metabolite formation.
Finnell RH; Bennett GD; Slattery JT; Amore BM; Bajpai M; Levy RH
Teratology; 1995 Dec; 52(6):324-32. PubMed ID: 8711619
[TBL] [Abstract][Full Text] [Related]
7. Hepatic foci of cellular and enzymatic alteration and nodules in rats treated with clofibrate or diethylnitrosamine followed by phenobarbital: their rate of onset and their reversibility.
Greaves P; Irisarri E; Monro AM
J Natl Cancer Inst; 1986 Mar; 76(3):475-84. PubMed ID: 2869179
[TBL] [Abstract][Full Text] [Related]
8. Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression.
Kinoshita A; Wanibuchi H; Morimura K; Wei M; Shen J; Imaoka S; Funae Y; Fukushima S
Carcinogenesis; 2003 Aug; 24(8):1389-99. PubMed ID: 12807726
[TBL] [Abstract][Full Text] [Related]
9. Combined supplementation of vanadium and beta-carotene suppresses placental glutathione S-transferase-positive foci and enhances antioxidant functions during the inhibition of diethylnitrosamine-induced rat liver carcinogenesis.
Chattopadhyay MB; C B MK; Kanna PS; Ray RS; Roy S; Chatterjee M
J Gastroenterol Hepatol; 2004 Jun; 19(6):683-93. PubMed ID: 15151625
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical detection and quantitation of microsomal cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate:cytochrome P-450 reductase in the rat ventral prostate.
Haaparanta T; Halpert J; Glaumann H; Gustafsson JA
Cancer Res; 1983 Nov; 43(11):5131-7. PubMed ID: 6413054
[TBL] [Abstract][Full Text] [Related]
11. Colocalized alterations in connexin32 and cytochrome P450IIB1/2 by phenobarbital and related liver tumor promoters.
Neveu MJ; Babcock KL; Hertzberg EL; Paul DL; Nicholson BJ; Pitot HC
Cancer Res; 1994 Jun; 54(12):3145-52. PubMed ID: 8205533
[TBL] [Abstract][Full Text] [Related]
12. Effect of phenobarbital and other liver monooxygenase modifiers on dimethylnitrosamine-induced alkylation of rat liver macromolecules.
Schwarz M; Buchmann A; Klormann H; Schrenk D; Kunz W
Cancer Res; 1985 May; 45(5):2020-4. PubMed ID: 3986758
[TBL] [Abstract][Full Text] [Related]
13. A mechanism of inhibition of aflatoxin B1-DNA binding in the liver by phenobarbital pretreatment of rats.
Lotlikar PD; Raj HG; Bohm LS; Ho LL; Jhee EC; Tsuji K; Gopalan P
Cancer Res; 1989 Feb; 49(4):951-7. PubMed ID: 2492210
[TBL] [Abstract][Full Text] [Related]
14. Influence of age, phenobarbital and beta-naphthoflavone on hepatic microsomal lipid peroxidation in rats.
Jahn F; Karge E; Klinger W
Z Versuchstierkd; 1990; 33(3):140-5. PubMed ID: 2402955
[TBL] [Abstract][Full Text] [Related]
15. Effects of dietary selenium concentration on the development of enzyme-altered liver foci and hepatocellular carcinoma induced by diethylnitrosamine or N-acetylaminofluorene in rats.
LeBoeuf RA; Laishes BA; Hoekstra WG
Cancer Res; 1985 Nov; 45(11 Pt 1):5489-95. PubMed ID: 2865004
[TBL] [Abstract][Full Text] [Related]
16. Effect of cytochrome P-450 and flavin-containing monooxygenase modifying factors on the in vitro metabolism of amiodarone by rat and rabbit.
Young RA; Mehendale HM
Drug Metab Dispos; 1987; 15(4):511-7. PubMed ID: 2888625
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P-450 isoenzyme content and monooxygenase activities in rat liver: effect of ontogenesis and pretreatment by phenobarbital and 3-methylcholanthrene.
Cresteil T; Beaune P; Celier C; Leroux JP; Guengerich FP
J Pharmacol Exp Ther; 1986 Jan; 236(1):269-76. PubMed ID: 3941398
[TBL] [Abstract][Full Text] [Related]
18. Different efficiency of various synthetic antioxidants towards NADPH induced chemiluminescence in rat liver microsomes.
Weimann A; Hildebrandt AG; Kahl R
Biochem Biophys Res Commun; 1984 Dec; 125(3):1033-8. PubMed ID: 6517931
[TBL] [Abstract][Full Text] [Related]
19. P-450 enzyme induction by 5-ethyl-5-phenylhydantoin and 5,5-diethylhydantoin, analogues of barbiturate tumor promoters phenobarbital and barbital, and promotion of liver and thyroid carcinogenesis initiated by N-nitrosodiethylamine in rats.
Diwan BA; Rice JM; Nims RW; Lubet RA; Hu H; Ward JM
Cancer Res; 1988 May; 48(9):2492-7. PubMed ID: 3356011
[TBL] [Abstract][Full Text] [Related]
20. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats.
Jeffery EH; Mannering GJ
Mol Pharmacol; 1983 May; 23(3):748-57. PubMed ID: 6865917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
